To test TLR signaling, we cultured dermal fibroblasts from individuals with SLOS with defined pathological DHCR7 variants (Supplemental Table 1 and Supplemental Methods; supplemental material available online with this article; https://doi.org/10.1172/JCI167633DS1). This evidence concerns the gene DHCR7 and Smith-Lemli-Opitz syndrome.